Bioventus (BVS) Deferred Taxes (2020 - 2026)
Bioventus (BVS) posted Deferred Taxes of $135000.0 for Q1 2026, up 111.94% on a QoQ basis from -$1.1 million in Q4 2025, and up 213.95% year-over-year from $43000.0 in Q1 2025.
Bioventus (BVS) Deferred Taxes (2020 - 2026) Analysis & Trends
Bioventus' Deferred Taxes history runs 7 years deep, the most recent figure standing at $135000.0 for Q1 2026.
- Quarterly Deferred Taxes rose 213.95% year-over-year to $135000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$817000.0 (up 84.96% YoY) and the FY2025 annual result came in at -$909000.0, up 83.15% from the prior year.
- Deferred Taxes was $135000.0 for Q1 2026 at Bioventus, up from -$1.1 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $3.2 million in Q4 2024 and bottomed at -$17.0 million in Q2 2022.
- A 5-year average of -$3.5 million and a median of -$693500.0 in 2023 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2022 — Deferred Taxes tumbled 20603.61% — and 2026, when it soared 213.95%.
- Bioventus' Deferred Taxes stood at -$11.8 million in 2022, then soared by 109.88% to $1.2 million in 2023, then surged by 176.44% to $3.2 million in 2024, then sank by 135.18% to -$1.1 million in 2025, then soared by 111.94% to $135000.0 in 2026.
- Business Quant data shows BVS's Deferred Taxes at $135000.0 in Q1 2026, -$1.1 million in Q4 2025, and $135000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -33.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -8.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -351.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -9.40 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 7.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 51.51 Mn |
| 10 | Bioventus | 837.84 Mn | 801.99 Mn | 90.77 Mn | 135,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 135,000.00 |
| Dec 31, 2025 | -1.13 Mn |
| Sep 27, 2025 | 135,000.00 |
| Jun 28, 2025 | 44,000.00 |
| Mar 29, 2025 | 43,000.00 |
| Dec 31, 2024 | 3.22 Mn |
| Sep 28, 2024 | -511,000.00 |
| Jun 29, 2024 | -8.18 Mn |
| Mar 30, 2024 | 81,000.00 |
| Dec 31, 2023 | 1.16 Mn |
| Jul 1, 2023 | -876,000.00 |
| Apr 1, 2023 | -2.66 Mn |
| Dec 31, 2022 | -11.77 Mn |
| Oct 1, 2022 | -7.19 Mn |
| Jul 2, 2022 | -10.68 Mn |
| Apr 2, 2022 | -17.02 Mn |
| Dec 31, 2021 | -8.05 Mn |
| Oct 2, 2021 | -722,000.00 |
| Jul 3, 2021 | -1.06 Mn |
| Apr 3, 2021 | 83,000.00 |